Compare Invesco India Pharma And Healthcare Fund vs SBI Healthcare Opportunities Fund
Invesco India Pharma And Healthcare Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
5.19
1.99
NAV
₹9.14
₹565.02
Fund Started
18 Aug 2026
04 Jun 1999
Fund Size
₹435.52 Cr
₹5870.00 Cr
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
Exit load of 0.50% if redeemed within 15 days
1 Year
-
12.47%
3 Year
-
20.35%
5 Year
-
15.74%
Equity
87.01%
95.53%
Cash
12.99%
4.41%
Top 10 Holdings
Name | Assets |
|---|---|
Max Healthcare Institute Ltd. | 9.58% |
Sun Pharmaceutical Industries Ltd. | 8.99% |
Sai Life Sciences Ltd. | 8.63% |
Apollo Hospitals Enterprise Ltd. | 8.03% |
Manipal Health Enterprises Ltd. | 7.98% |
Divi's Laboratories Ltd. | 7.85% |
Global Health Ltd. | 7.00% |
Dr. Agarwal's Health Care Ltd. | 6.32% |
CORONA Remedies Ltd. | 6.13% |
Torrent Pharmaceuticals Ltd. | 4.93% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.14% |
Divi's Laboratories Ltd. | 7.91% |
Acutaas Chemicals Ltd. | 5.03% |
Apollo Hospitals Enterprise Ltd. | 4.45% |
Torrent Pharmaceuticals Ltd. | 4.42% |
Cipla Ltd. | 4.40% |
Laurus Labs Ltd. | 4.05% |
Max Healthcare Institute Ltd. | 3.80% |
Aurobindo Pharma Ltd. | 3.42% |
Aster DM Quality Care Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
18 Aug 2026
04 Jun 1999
